The Pathogenic Role of PI3K/AKT Pathway in Cancer Onset and Drug Resistance: An Updated Review.
Rascio F, Spadaccino F, Rocchetti MT, Castellano G, Stallone G, Netti GS, Ranieri E. · 2021
Read The Pathogenic Role of PI3K/AKT Pathway in Cancer Onset and Drug Resistance: An Updated Review. by Rascio F, Spadaccino F, Rocchetti MT, Castellano G, Stallone G, Netti GS, Ranieri E. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8394096.txt.
Description
Rascio and co-authors update the evidence on the PI3K/AKT pathway in cancer growth and drug resistance. This signaling path is among the most often over-activated in human cancers. It drives tumor growth, spread, and invasion. Drug resistance, in turn, drives most cancer deaths.
The review traces how the pathway goes wrong at many levels. Mutations, gene changes, faulty small RNA control, and abnormal protein activation all play a part. Such faults blunt common cancer treatments. The authors argue that combined and personalized therapy should take this pathway into account. Doing so may sharpen treatment choices and improve results against resistant disease.
Catalog record
| CREATOR | Rascio F, Spadaccino F, Rocchetti MT, Castellano G, Stallone G, Netti GS, Ranieri E. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 64 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |